Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 1055

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 11
Chunk 1055
---
 between CERo Therapeutics
    Holdings, Inc. and the investors named therein (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed
    by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on September 25, 2024).

    10.24
     
    Registration Rights Agreement, dated as of September 26, 2024, by and between CERo Therapeutics
    Holdings, Inc. and the investors party thereto (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed
    by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on September 25, 2024).

    10.25
     
    Consent and Waiver Agreement, dated as of September 26, 2024, by and between CERo Therapeutics
    Holdings, Inc. and the investors party thereto (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed
    by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on September 25, 2024).

    10.26
     
    Common Stock Purchase Agreement, dated as of November 8, 2024, by and between CERo Therapeutics
    Holdings, Inc. and Keystone Capital Partners, LLC (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed
    by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on November 12, 2024).

116

    10.27
     
    Registration Rights Agreement, dated as of November 8, 2024, by and between CERo Therapeutics Holdings,
    Inc. and Keystone Capital Partners, LLC (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K/A filed by CERo
    Therapeutics Holdings, Inc. with the Securities and Exchange Commission on November 12, 2024).

    10.28
     
    Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on February 6, 2025).

    10.29